ViaCyte Appoints Marty Lorenzo as General Counsel

SAN DIEGO, Nov. 30, 2021 -- (Healthcare Sales & Marketing Network) -- ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet needs, today announced the appointme... Regenerative Medicine, Personnel ViaCyte, cell therapy, diabetes
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news